FI114705B - Kinolonderivat för behandling av urininkontinens - Google Patents

Kinolonderivat för behandling av urininkontinens Download PDF

Info

Publication number
FI114705B
FI114705B FI964019A FI964019A FI114705B FI 114705 B FI114705 B FI 114705B FI 964019 A FI964019 A FI 964019A FI 964019 A FI964019 A FI 964019A FI 114705 B FI114705 B FI 114705B
Authority
FI
Finland
Prior art keywords
compound
cyanophenyl
trifluoromethyl
att
formula
Prior art date
Application number
FI964019A
Other languages
English (en)
Finnish (fi)
Other versions
FI964019A0 (sv
FI964019A (sv
Inventor
Diane Amy Trainor
James Michael Hulsizer
Jr Cyrus John Ohnmacht
John Edward Warawa
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of FI964019A0 publication Critical patent/FI964019A0/sv
Publication of FI964019A publication Critical patent/FI964019A/sv
Application granted granted Critical
Publication of FI114705B publication Critical patent/FI114705B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI964019A 1994-04-14 1996-10-07 Kinolonderivat för behandling av urininkontinens FI114705B (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9407432 1994-04-14
GB9407432A GB9407432D0 (en) 1994-04-14 1994-04-14 Heterocyclic derivative
GB9500845 1995-04-13
PCT/GB1995/000845 WO1995028388A1 (en) 1994-04-14 1995-04-13 Quinolone derivative for treatment of urinary incontinence

Publications (3)

Publication Number Publication Date
FI964019A0 FI964019A0 (sv) 1996-10-07
FI964019A FI964019A (sv) 1996-10-07
FI114705B true FI114705B (sv) 2004-12-15

Family

ID=10753541

Family Applications (2)

Application Number Title Priority Date Filing Date
FI964019A FI114705B (sv) 1994-04-14 1996-10-07 Kinolonderivat för behandling av urininkontinens
FI20040352A FI115630B (sv) 1994-04-14 2004-03-04 Förfarande för framställning av 4-(3-cyanfenyl)-2-trifluormetyl-5-oxo-1,4,5,6,7,8-hexahydrokinolin-3-karboxylsyra

Family Applications After (1)

Application Number Title Priority Date Filing Date
FI20040352A FI115630B (sv) 1994-04-14 2004-03-04 Förfarande för framställning av 4-(3-cyanfenyl)-2-trifluormetyl-5-oxo-1,4,5,6,7,8-hexahydrokinolin-3-karboxylsyra

Country Status (25)

Country Link
EP (1) EP0755382B1 (sv)
JP (1) JP3782445B2 (sv)
KR (1) KR100344885B1 (sv)
CN (1) CN1058708C (sv)
AT (1) ATE202089T1 (sv)
AU (1) AU700773B2 (sv)
BR (1) BR9507366A (sv)
CA (1) CA2187525C (sv)
CZ (1) CZ284652B6 (sv)
DE (1) DE69521310T2 (sv)
DK (1) DK0755382T3 (sv)
ES (1) ES2159633T3 (sv)
FI (2) FI114705B (sv)
GB (1) GB9407432D0 (sv)
GR (1) GR3036482T3 (sv)
HK (1) HK1013999A1 (sv)
HU (1) HU215387B (sv)
MX (1) MX9603920A (sv)
NO (1) NO307177B1 (sv)
NZ (1) NZ283779A (sv)
PL (2) PL183095B1 (sv)
PT (1) PT755382E (sv)
RU (1) RU2149870C1 (sv)
SK (1) SK281124B6 (sv)
WO (1) WO1995028388A1 (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2292462T3 (es) * 1999-08-03 2008-03-16 Abbott Laboratories Agentes abridores de los canales del potasio.
WO2002010134A1 (en) * 2000-08-02 2002-02-07 Astrazeneca Ab Process for asymmetric synthesis of substituted 1,4-dihydropyridines
SE0200205D0 (sv) * 2002-01-24 2002-01-24 Astrazeneca Ab Method
CN102532015B (zh) * 2012-01-18 2013-10-23 云南大学 香豆素及其类似物的固相合成方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2003148A1 (de) * 1970-01-24 1971-07-29 Bayer Ag Neue 1,4-Dihydropyridinderivate
GB9220570D0 (en) * 1991-10-21 1992-11-11 Ici Plc Therapeutic agent
GB9318935D0 (en) * 1992-10-20 1993-10-27 Zeneca Ltd Heterocyclic derivatives

Also Published As

Publication number Publication date
PL183095B1 (pl) 2002-05-31
PL316790A1 (en) 1997-02-17
PL182031B1 (pl) 2001-10-31
SK281124B6 (sk) 2000-12-11
FI964019A0 (sv) 1996-10-07
NO307177B1 (no) 2000-02-21
CA2187525A1 (en) 1995-10-26
ES2159633T3 (es) 2001-10-16
KR100344885B1 (ko) 2002-11-30
HK1013999A1 (en) 1999-09-17
CN1146202A (zh) 1997-03-26
CZ298196A3 (en) 1997-02-12
FI964019A (sv) 1996-10-07
DE69521310D1 (de) 2001-07-19
PT755382E (pt) 2001-11-30
CN1058708C (zh) 2000-11-22
NZ283779A (en) 1998-02-26
HUT76132A (en) 1997-06-30
GR3036482T3 (en) 2001-11-30
JP3782445B2 (ja) 2006-06-07
CA2187525C (en) 2006-01-24
GB9407432D0 (en) 1994-06-08
AU2219995A (en) 1995-11-10
CZ284652B6 (cs) 1999-01-13
NO964345D0 (no) 1996-10-11
ATE202089T1 (de) 2001-06-15
FI20040352A (sv) 2004-03-04
AU700773B2 (en) 1999-01-14
BR9507366A (pt) 1997-09-23
RU2149870C1 (ru) 2000-05-27
FI115630B (sv) 2005-06-15
EP0755382B1 (en) 2001-06-13
WO1995028388A1 (en) 1995-10-26
NO964345L (no) 1996-12-11
SK131796A3 (en) 1997-05-07
DE69521310T2 (de) 2002-04-18
JPH09512254A (ja) 1997-12-09
EP0755382A1 (en) 1997-01-29
HU9602747D0 (en) 1996-11-28
MX9603920A (es) 1997-04-30
DK0755382T3 (da) 2001-09-10
HU215387B (hu) 1998-12-28

Similar Documents

Publication Publication Date Title
AU654148B2 (en) R(+)-terazosin
RU2659784C2 (ru) Сложноэфирное хиральное соединение (n-замещенный имидазол)-карбоновой кислоты, содержащее простую эфирную боковую цепь, его получение и применение
KR100296657B1 (ko) 요실금치료용퀴놀론및아크리딘온유도체
US5484792A (en) 1,8-(2H,5H)-acridinedione therapeutic agents
FI90545C (sv) Förfarande för framställning av terapeutiskt aktiva 2,2-dimetylkromenderivat
EP0024960B1 (fr) Nouvelles phénoxyamines hétérocycliques substituées, procédé pour leur préparation et leur application comme anesthésiques locaux
FI114705B (sv) Kinolonderivat för behandling av urininkontinens
US5455253A (en) Heterocyclic derivatives
JPH04178356A (ja) 光学活性なベンジルアルコール誘導体及びその用途
AU731407B2 (en) Quinolone derivative for treatment of urinary incontinence
CN110066310A (zh) 丹参酮iia噻吩吡啶类化合物及其制备方法和用途
JPH0656833A (ja) 血液循環の中断による神経損傷を治療するためのキサンチン誘導体の使用